Immune therapy engineered inside the body eases multiple sclerosis Results from a small trial suggest a modified virus can instruct the immune system to wipe out disease-causing cells. By Rachel Fieldhouse

https://www.nature.com/articles/d41586-026-02765-1

Daily briefing: GLP-1 obesity drugs slow signs of ageing in mice Mice on GLP-1s also performed better on cognitive tasks than those on a calorie restricted diet . Plus, satellite images showed early warning signs of glacier collapse near the Nepal–Tibet border and the impact of people saying fewer words aloud. By Jacob Smith

https://www.nature.com/articles/d41586-026-02781-1

Late-life semaglutide treatment slows ageing and extends lifespan in female mice Yufan Feng, Marine Barthez, Yifei Wang, Yibing Chen, Huixian Qiu, Chih-Ling Wang, Kartoosh Heydari, Melaine Delcroix, Lene Juel Rasmussen, Vilhelm A. Bohr & Danica Chen

https://www.nature.com/articles/s41586-026-10940-7

Magic-mushroom compound blocks a severe side effect of chemotherapy in mice Study shows that psilocybin acts on nerves to prevent the painful condition called peripheral neuropathy. By Max Kozlov

https://www.nature.com/articles/d41586-026-02744-6

Anxious or outgoing? Huge study links ‘Big Five’ personality traits to genetic variants Researchers identify more than 1,200 personality-linked genetic variants, with effects largely independent of family background. By Ewen Callaway

https://www.nature.com/articles/d41586-026-02761-5

Can GLP-1 drugs slow ageing? Mouse study shows promise Older female mice given an anti-obesity medication lived longer and in better health than did mice not taking one. By Mariana Lenharo

https://www.nature.com/articles/d41586-026-02757-1?utm_source=Live+Audience&utm_campaign=daaefd5c41-nature-briefing-daily-20260903&utm_medium=email&utm_term=0_-33f35e09ea-50432164

Medscape Medical News, September 04, 2026 (+...) ++++

https://www.medscape.com/index/list_13474_0 Avacopan in Vasculitis: Uncommon but Severe Liver Risks Avacopan in Vasculitis: Uncommon but Severe Liver Risks Liver enzyme elevations related to avacopan therapy are uncommon in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, although drug-induced liver injury may occur. Medscape Medical News, September 04, 2026 https://www.medscape.com/viewarticle/avacopan-linked-uncommon-severe-liver-injury-patients-anca-2026a1000wyq Does Pediatric ALL Therapy Work Long-Term in Young Adults? Researchers evaluate the 10-year outcomes of a pediatric-inspired regimen in adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Medscape Medical News, September 04, 2026 https://www.medscape.com/viewarticle/does-pediatric-all-therapy-work-long-term-young-adults-2026a1000wj1 Talc Powder Not Linked to Lung Cancer in Women A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open. Medscape Medical News, September 04, 2026 https://www.medscape.com/viewarticle/talc-powder-not-linked-lung-cancer-women-2026a1000wyj Does Liver Disease Affect Cholangiocarcinoma Outcomes? Patients diagnosed with cholangiocarcinoma who have preexisting chronic liver disease experience improved survival compared with those who do not have prior chronic liver disease. Medscape News UK, September 04, 2026 https://www.medscape.com/viewarticle/does-chronic-liver-disease-affect-cholangiocarcinoma-2026a1000wk2